A genetic variant in IL-6 lowering its expression is protective for critical patients with COVID-19
Abstract Critical coronavirus disease 2019 (COVID-19) is associated with high mortality and potential genetic factors have been reported to be involved in the development of critical COVID-19. We performed a genome-wide association study to identify the genetic factors responsible for developing cri...
Main Authors: | Bo Gong, Lulin Huang, Yongquan He, Wen Xie, Yi Yin, Yi Shi, Jialing Xiao, Ling Zhong, Yi Zhang, Zhilin Jiang, Fang Hao, Yu Zhou, Huan Li, Li Jiang, Xingxiang Yang, Xiangrong Song, Yan Kang, Lin Tuo, Yi Huang, Ping Shuai, Yuping Liu, Fang Zheng, Zhenglin Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2022-04-01
|
Series: | Signal Transduction and Targeted Therapy |
Online Access: | https://doi.org/10.1038/s41392-022-00923-1 |
Similar Items
-
Dynamic blood single-cell immune responses in patients with COVID-19
by: Lulin Huang, et al.
Published: (2021-03-01) -
CTNND1 variants cause familial exudative vitreoretinopathy through the Wnt/cadherin axis
by: Mu Yang, et al.
Published: (2022-07-01) -
Single-cell transcriptome reveals diversity of Müller cells with different metabolic-mitochondrial signatures in normal and degenerated macula
by: Bei Liu, et al.
Published: (2022-12-01) -
Association study of candidate genes for susceptibility to Kashin-Beck disease in a Tibetan population
by: Zhengfu Tai, et al.
Published: (2017-06-01) -
ANGPTL4 variants and their haplotypes are associated with serum lipid levels, the risk of coronary artery disease and ischemic stroke and atorvastatin cholesterol-lowering responses
by: Qian Yang, et al.
Published: (2018-10-01)